iRGD-Functionalized Graphene–Silver Nanohybrids for Enhanced Blood–Brain Barrier Transport and Tumor Penetration in Glioma Models
ACS Applied Bio Materials · 02.11.2026 · 9 (21) · 10129-10151
DOI: 10.1021/acsabm.6c00709 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, online erschienen am 12.10.2026. Verfasst von Vianni Chopra und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Engineering and Sciences, Tecnologico de Monterrey, Av. Eugenio Garza Sada 2501 Sur, Monterrey, NL64849, Mexico. Hauptthemen laut MEDLINE: Glioma, Graphite, Silver, Doxorubicin. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Sistema Nacional de Investigadores, Sistema Nacional de Investigación, Secretaría Nacional de Ciencia, Tecnología e Innovación, Sistema Nacional de Investigaci?n, Secretar?a Nacional de Ciencia, Tecnolog?a e Innovaci?n.
Abstract (Originalsprache)
Efficient drug delivery across both the tumor microenvironment and the blood–brain barrier (BBB) remains a major challenge in glioblastoma therapy, where dense cellular architecture and endothelial restriction severely limit treatment efficacy. Here, we report the rational design of a multifunctional nanoplatform, Dox[iRGD-GO@AgNP], integrating graphene oxide (GO), silver nanoparticles (AgNPs), and a cyclic iRGD tumor-penetrating peptide to enhance doxorubicin (Dox) transport, tumor penetration, and intracellular delivery. Comprehensive physicochemical characterization confirmed successful synthesis, surface functionalization, colloidal stability, and efficient drug loading. In two-dimensional C6 glioma cell monolayers, cyclic iRGD-functionalized nanohybrids demonstrated significantly enhanced intracellular Dox accumulation compared to free drug and nontargeted controls. These effects were further amplified in three-dimensional glioma spheroids, where Dox[iRGD-GO@AgNP] achieved deep tumor penetration (>80 µm) and more homogeneous intratumoral distribution. Enhanced delivery translated into superior therapeutic efficacy, as evidenced by reduced cell viability, increased membrane damage, upregulation of apoptosis-related markers (p53 and caspase-3 &9), and pronounced morphological disruption confirmed by fluorescence imaging and electron microscopy. To evaluate endothelial transport, a Transwell-based bEnd.3 BBB model was established and validated by transendothelial electrical resistance measurements and tight junction imaging. Cyclic iRGD-functionalized nanohybrids exhibited significantly enhanced transendothelial transport while preserving BBB integrity, indicating ligand-mediated transport rather than nonspecific barrier disruption. Importantly, improved BBB traversal resulted in increased drug accumulation in downstream glioma cells and spheroids. These composites showed anti-angiogenic properties in ovo CAM model. Overall, this study integrates rational nanocomposite design with a hierarchical in vitro evaluation framework spanning material characterization, tumor-relevant 2D and 3D models, and BBB transport. The Dox[iRGD-GO@AgNP] platform addresses key delivery and efficacy barriers in glioblastoma and provides a translationally relevant strategy for the development of BBB-penetrating nanotherapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Engineering and Sciences, Tecnologico de Monterrey, Av. Eugenio Garza Sada 2501 Sur, Monterrey, NL64849, Mexico.
ORCID-Profile: Vianni Chopra, Carlos Eduardo Fajardo Barocio, Gaurav Chauhan
Förderung
- Sistema Nacional de Investigadores
- Sistema Nacional de Investigación, Secretaría Nacional de Ciencia, Tecnología e Innovación
- Sistema Nacional de Investigaci?n, Secretar?a Nacional de Ciencia, Tecnolog?a e Innovaci?n
- Semiconductor and Nanotechnology Research Group at Tecnologico de Monterrey
Zitieren
APA
Chopra, V., Siono, J. A. G., Fajardo Barocio, C. E., & Chauhan, G. (2026). iRGD-Functionalized Graphene–Silver Nanohybrids for Enhanced Blood–Brain Barrier Transport and Tumor Penetration in Glioma Models. ACS Applied Bio Materials, 9(21), 10129-10151. https://doi.org/10.1021/acsabm.6c00709
Vancouver
Chopra V, Siono JAG, Fajardo Barocio CE, Chauhan G. iRGD-Functionalized Graphene–Silver Nanohybrids for Enhanced Blood–Brain Barrier Transport and Tumor Penetration in Glioma Models. ACS Applied Bio Materials. 2026;9(21):10129-10151. doi:10.1021/acsabm.6c00709
BibTeX
@article{Chopra2026,
author = {Chopra, Vianni and Siono, Jocelyn Alexandra Gómez and Fajardo Barocio, Carlos Eduardo and Chauhan, Gaurav},
title = {iRGD-Functionalized Graphene–Silver Nanohybrids for Enhanced Blood–Brain Barrier Transport and Tumor Penetration in Glioma Models},
journal = {ACS Applied Bio Materials},
year = {2026},
volume = {9},
number = {21},
pages = {10129--10151},
doi = {10.1021/acsabm.6c00709}
}
EUVIMED